SACT protocols

 

Although these pages are public, the chemotherapy information within them is for Cancer Alliance staff and therefore the language may appear confusing to those who do not work in this area. 

Disclaimer:
The SACT protocols available on this website are maintained by the Lancashire and South Cumbria network pharmacist David Barber. The Cancer Alliance is not responsible for the content or upkeep of the protocols. If you have any queries about the protocols please contact David Barber: Tel 01772 522339 or david.barber@lthtr.nhs.uk

For the management of acute oncology and immunotherapy toxicities please visit the acute oncology CRG page via the below link:

 
 

Cancer Alliance Clinical Trials- (Summaries for out of hours)

Amplitude - Clinical trials summary for out of hours Astefania - Clinical trials summary for out of hours AURORA Study - Clinical trials summary for out of hours BL13 - Clinical trials summary for out of hours (A RANDOMIZED PHASE II TRIAL ASSESSINGTRIMODALITY THERAPY WITH OR WITHOUT ADJUVANT DURVALUMAB (MEDI4736) TO TREAT PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER) BNT122-01 Clinical Trials Summary for out of hours.pdf Checkmate 848 Solid Tumour Trial CA209848 - Clinical trials summary for out of hours COLUMBUS AD - EORTC - Clinical trials summary for out of hours Couplet - Clinical trials summary for out of hours- Phase 1b V 1 10-10-18 (October 2018) CYPIDES - Clinical Study Protocol (Version 12) CYPIDES - Clinical trials summary for out of hours DECIPHER- Clinical trials summary for out of hours.pdf HeredERA - Clinical trials summary for out of hours Imvigor011 - Clinical trials summary for out of hours JAVELIN - Clinical trials summary for out of hours lidERA (GO42784) - Clinical trials summary for out of hours MK3475-992_IRAS 1003217_Clinical Trials Summary for out of hours.docx MK3475-U03 - Clinical trials summary for out of hours MODIFY MODI1 - Clinical trials summary for out of hours MORAb - 202-G000-20 - Clinical trials summary for out of hours POD1UM303 - Clinical trials summary for out of hours SCOPE Study- Clinical trials summary for out of hours Seattle GENETICS EV302 - Clinical trials summary for out of hours Shattuck Labs SL03-OHD-105 - Clinical trials summary for out of hours Shattuck Labs SL03-OHD-105 - Mirvetuximab Soravtansine - CHEMOTHERAPY INSTRUCTIONS STELLAR Study XL092-001- Clinical trials summary for out of hours SUNRISE4 - Clinical trials summary for out of hours TALAPRO - Clinical trials out of hours summary.pdf TRIDENT Commercial Study - Clinical trials summary for out of hours TROPiCS-04 - Clinical trials summary for out of hours WO43919 - INAVO121 IRAS 1007071_Clinical Trials Summary for out of hours.docx

Accessibility tools

Return to header